Free Trial

OncoCyte (OCX) Short Interest Ratio & Short Volume

OncoCyte logo
$3.00
-0.03 (-0.99%)
(As of 11/1/2024 ET)

OncoCyte Short Interest Data

OncoCyte (OCX) has a short interest of 189,300 shares, representing 1.39% of the float (the number of shares available for trading by the public). This marks a 5.40% increase in short interest from the previous month. The short interest ratio (days to cover) is 9.6, indicating that it would take 9.6 days of the average trading volume of 36,171 shares to cover all short positions.

Current Short Interest
189,300 shares
Previous Short Interest
179,600 shares
Change Vs. Previous Month
+5.40%
Dollar Volume Sold Short
$590,616.00
Short Interest Ratio
9.6 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
16,830,000 shares
Float Size
13,640,000 shares
Short Percent of Float
1.39%
Today's Trading Volume
27,219 shares
Average Trading Volume
36,171 shares
Today's Volume Vs. Average
75%
Short Selling OncoCyte?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for OncoCyte and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

OCX Short Interest Over Time

OCX Days to Cover Over Time

OCX Percentage of Float Shorted Over Time

OncoCyte Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/2024189,300 shares $590,616.00 +5.4%1.4%9.6 $3.12
9/30/2024179,600 shares $511,860.00 -1.8%1.5%7.4 $2.85
9/15/2024182,900 shares $563,332.00 -3.8%1.5%5.8 $3.08
8/31/2024190,200 shares $597,228.00 -6.4%1.6%5.6 $3.14
8/15/2024203,100 shares $599,145.00 -10.2%1.7%5.7 $2.95
7/31/2024226,100 shares $709,954.00 -22.4%1.9%5.9 $3.14
7/15/2024291,300 shares $978,768.00 -36.4%2.5%7.3 $3.36
6/30/2024458,300 shares $1.35 million +22.3%3.9%6 $2.95
6/15/2024374,600 shares $1.03 million -2.6%3.2%5.6 $2.76
5/31/2024384,500 shares $1.05 million +10.0%3.4%6.2 $2.74
5/15/2024349,700 shares $1.01 million -6.6%3.1%5.7 $2.89
4/30/2024374,200 shares $931,758.00 +60.5%3.6%6.6 $2.49
4/15/2024233,100 shares $589,743.00 +30.2%3.1%4.2 $2.53
3/31/2024179,100 shares $524,763.00 +0.5%2.4%21.3 $2.93
3/15/2024178,300 shares $531,334.00 +0.4%2.4%13.5 $2.98
2/29/2024177,600 shares $516,816.00 -2.8%2.3%13.1 $2.91
2/15/2024182,800 shares $524,636.00 -1.5%2.4%14.3 $2.87
1/31/2024185,600 shares $575,360.00 -5.7%2.4%10.3 $3.10
1/15/2024196,800 shares $661,248.00 +8.3%2.6%10.6 $3.36
12/31/2023181,800 shares $454,500.00 -4.4%2.4%9.2 $2.50
12/15/2023190,100 shares $589,310.00 -10.4%2.5%11.7 $3.10
11/30/2023212,200 shares $806,360.00 +4.7%2.8%14.4 $3.80
11/15/2023202,600 shares $802,296.00 -1.1%2.7%13.2 $3.96
10/31/2023204,800 shares $464,896.00 +8.4%2.7%15.8 $2.27
10/15/2023188,900 shares $612,980.50 +0.9%2.5%9.9 $3.25
9/30/2023187,200 shares $584,064.00 +0.7%2.5%10 $3.12
9/15/2023185,900 shares $593,021.00 +8.3%2.5%9.4 $3.19
8/31/2023171,600 shares $616,044.00 +3.5%2.3%8.2 $3.59
8/15/2023165,800 shares $553,772.00 +157.9%2.2%7.9 $3.34
7/31/202364,300 shares $268,131.00 +43.2%0.9%3.2 $4.17
7/15/202344,900 shares $195,135.40 -95.6%N/A3.5 $4.35
6/30/20231,020,000 shares $234,600.00 -4.7%N/A3.4 $0.23
6/15/20231,070,000 shares $230,050.00 -24.7%N/A3.2 $0.22
5/31/20231,420,000 shares $303,454.00 +22.4%N/A2.7 $0.21
5/15/20231,160,000 shares $308,560.00 -2.5%N/A2.3 $0.27
4/30/20231,190,000 shares $326,060.00 -14.4%N/A2.4 $0.27
4/15/20231,390,000 shares $443,688.00 +5.3%N/A2.8 $0.32
3/31/20231,320,000 shares $467,808.00 +6.5%N/A2.8 $0.35
3/15/20231,240,000 shares $248,000.00 +24.0%N/A2.7 $0.20
2/28/20231,000,000 shares $363,900.00 -4.8%N/A3.6 $0.36
625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

2/15/20231,050,000 shares $471,975.00 -13.2%N/A3.6 $0.45
1/31/20231,210,000 shares $465,971.00 -14.2%N/A3.1 $0.39
1/15/20231,410,000 shares $688,080.00 -16.6%N/A3.4 $0.49
12/30/20221,690,000 shares $542,321.00 -14.7%N/A4.1 $0.32
12/15/20221,980,000 shares $792,000.00 -4.4%N/A5.1 $0.40
11/30/20222,070,000 shares $973,107.00 -12.7%N/A6.5 $0.47
11/15/20222,370,000 shares $967,908.00 -6.3%N/A6.1 $0.41
10/31/20222,530,000 shares $1.73 million -1.9%N/A7.9 $0.68
10/15/20222,580,000 shares $2.00 million -1.5%N/A9.1 $0.78
9/30/20222,620,000 shares $1.91 million +5.7%N/A8.8 $0.73
9/15/20222,480,000 shares $2.23 million -8.2%N/A5.6 $0.90
8/31/20222,700,000 shares $2.13 million No ChangeN/A5.5 $0.79
7/30/20213,040,000 shares $0.00 -3.8%3.6%6.9 $0.00
7/15/20213,160,000 shares $0.00 +2.6%3.6%6.9 $0.00
6/30/20213,080,000 shares $0.00 -4.6%3.6%6.2 $0.00
6/15/20213,230,000 shares $0.00 +14.1%3.8%6.4 $0.00
5/28/20212,830,000 shares $0.00 +2.9%3.3%4.5 $0.00
5/14/20212,750,000 shares $0.00 -0.4%N/A3.6 $0.00
4/30/20212,760,000 shares $0.00 +0.7%N/A2.9 $0.00
4/15/20212,740,000 shares $12.38 million +19.7%N/A2.2 $4.52
3/31/20212,290,000 shares $11.45 million +9.1%N/A1.6 $5.00
3/15/20212,100,000 shares $10.94 million +6.1%N/A1.4 $5.21
2/26/20211,980,000 shares $9.41 million +4.2%6.6%0.8 $4.75
2/12/20211,900,000 shares $7.07 million -4.5%N/A0.8 $3.72
1/29/20211,990,000 shares $11.66 million -21.3%N/A0.9 $5.86
1/15/20212,530,000 shares $14.07 million +1.2%N/A1.3 $5.56
12/31/20202,500,000 shares $6.08 million +12.6%N/A1.1 $2.43
12/15/20202,220,000 shares $4.71 million -14.3%N/A1.1 $2.12
11/30/20202,590,000 shares $4.64 million +7.5%N/A2.7 $1.79
11/15/20202,410,000 shares $4.19 million -0.8%N/A2.3 $1.74
10/30/20202,430,000 shares $3.86 million +4.3%N/A2.3 $1.59
10/15/20202,330,000 shares $4.08 million -17.1%N/A1.9 $1.75
9/30/20202,810,000 shares $3.91 million +24.9%N/A3.3 $1.39
9/15/20202,250,000 shares $3.26 million +23.6%N/A2 $1.45
8/31/20201,820,000 shares $2.28 million +8.3%N/A1.6 $1.25
8/14/20201,680,000 shares $2.94 million -5.6%N/A1.7 $1.75
7/31/20201,780,000 shares $2.40 million +2.3%N/A1.8 $1.35
7/15/20201,740,000 shares $2.21 million -7.0%N/A2.2 $1.27
6/30/20201,870,000 shares $6.04 million +52.0%N/A2.7 $3.23
6/15/20201,230,000 shares $2.93 million +4.2%N/A3.4 $2.38
5/29/20201,180,000 shares $3.10 million +0.9%N/A4.3 $2.63
5/15/20201,170,000 shares $3.40 million +1.7%N/A4.6 $2.91
4/30/20201,150,000 shares $3.11 million -1.7%N/A5.2 $2.70
4/15/20201,170,000 shares $2.71 million -1.7%2.4%6.8 $2.32
3/31/20201,190,000 shares $2.84 million -9.4%2.5%4.6 $2.39
3/13/20201,313,100 shares $3.20 million +1.8%3.2%4.5 $2.44
2/28/20201,290,000 shares $2.49 million +7.5%2.7%4.4 $1.93
2/14/20201,200,000 shares $2.75 million +5.3%2.5%3.9 $2.29
1/31/20201,140,000 shares $2.87 million -1.7%2.4%3.8 $2.52
1/15/20201,160,000 shares $2.90 million -7.2%2.5%4 $2.50
625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

12/31/20191,250,000 shares $3.49 million No Change2.7%4.8 $2.79

OCX Short Interest - Frequently Asked Questions

What is OncoCyte's current short interest?

Short interest is the volume of OncoCyte shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 189,300 shares of OCX short. 1.39% of OncoCyte's shares are currently sold short. Learn More on OncoCyte's current short interest.

What is a good short interest ratio for OncoCyte?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OCX shares currently have a short interest ratio of 10.0. Learn More on OncoCyte's short interest ratio.

What is a good short interest percentage for OncoCyte?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.39% of OncoCyte's floating shares are currently sold short.

Is OncoCyte's short interest increasing or decreasing?

OncoCyte saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 189,300 shares, an increase of 5.4% from the previous total of 179,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is OncoCyte's float size?

OncoCyte currently has issued a total of 16,830,000 shares. Some of OncoCyte's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. OncoCyte currently has a public float of 13,640,000 shares.

How does OncoCyte's short interest compare to its competitors?

1.39% of OncoCyte's shares are currently sold short. Here is how the short interest of companies compare to OncoCyte: DURECT Co. (3.30%), Achilles Therapeutics plc (0.55%), ImmuCell Co. (0.18%), DBV Technologies S.A. (0.35%), Aspira Women's Health Inc. (4.03%), InflaRx (0.41%), Vincerx Pharma, Inc. (2.82%), Gossamer Bio, Inc. (3.07%), Instil Bio, Inc. (26.37%), Zentalis Pharmaceuticals, Inc. (10.77%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short OncoCyte stock?

Short selling OCX is an investing strategy that aims to generate trading profit from OncoCyte as its price is falling. OCX shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against OncoCyte?

A short squeeze for OncoCyte occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OCX, which in turn drives the price of the stock up even further.

How often is OncoCyte's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OCX, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:OCX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners